United States Antimony (NYSEAMERICAN:UAMY) has received a significant upgrade from HC Wainwright, which raised its price target from $8.50 to $10.25 in a recent research report. This adjustment, communicated to investors on October 20, 2023, accompanies a maintained “buy” rating for the stock. HC Wainwright also projected the company’s earnings per share (EPS) for fiscal year 2026 at $0.29.
Several other financial institutions have recently provided insights on United States Antimony. D. Boral Capital reaffirmed a “buy” rating and set a target price of $5.00 on August 14, while William Blair initiated coverage with an “outperform” rating. Currently, one analyst has given a “Strong Buy” rating, while five others have assigned a “Buy” rating, creating a consensus rating of “Buy” with an average target price of $4.81 according to data from MarketBeat.
Company Performance and Financial Insights
United States Antimony reported its earnings results on November 12, 2023, revealing an EPS of ($0.04) for the quarter, alongside revenues of $8.70 million. The company is currently experiencing a challenging financial landscape, indicated by a negative net margin of 45.32% and a return on equity of (16.58%). For the current fiscal year, analysts project that the company will post an EPS of (0.01).
In a notable development, CEO Gary C. Evans acquired 100,000 shares of United States Antimony on September 26, 2023, at an average price of $6.13 per share, amounting to a total of $613,000. Following this transaction, Evans now owns approximately 2,378,818 shares valued at around $14,582,154.34, representing a 4.39% increase in his holdings. This acquisition was disclosed in a filing with the Securities and Exchange Commission.
Institutional Investment Activity
Recent trading activity indicates a shift among institutional investors regarding United States Antimony. Notably, Two Sigma Investments LP increased its stake by 17.8% during the third quarter, now holding 278,047 shares valued at approximately $1,724,000. Soviero Asset Management LP also expanded its position by 52.9%, acquiring an additional 270,000 shares for a total of $4,836,000.
Furthermore, Bridgeway Capital Management LLC raised its holdings by 179.9% and now owns 77,800 shares valued at $482,000. Jump Financial LLC entered the picture with a new stake valued at around $4,305,000, while Invesco Ltd. significantly increased its holdings by 739.0% to own 506,925 shares worth approximately $3,143,000. Currently, institutional investors hold about 9.49% of the company’s stock.
United States Antimony operates in the production and sale of antimony, silver, gold, and zeolite products across the United States and Canada. The company has three primary segments: Antimony, Zeolite, and Precious Metals. Its antimony oxide is predominantly utilized in flame retardant systems for various materials, while antimony trisulfide serves as a primer in ammunition.
As the company navigates its financial challenges, analysts and investors will be closely monitoring its performance and strategic initiatives in the coming quarters.
